HCW Biologics (HCWB) Gross Margin (2022 - 2026)
HCW Biologics' Gross Margin was -69.25% in Q2 2026, down 89.25 percentage points from 20.00% a year earlier and down 169.09 percentage points from the prior quarter.
HCW Biologics (HCWB) Gross Margin (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, HCW Biologics' Gross Margin was 95.91% through Jun 30, 2026, up 75.91 percentage points year-over-year; for FY2025, it was 20.00%, down 17.38 percentage points from FY2024.
- Gross Margin shows a three-year change of -18.48 percentage points (FY2022 to FY2025).
- In earlier years, Gross Margin was 37.38% in FY2024 (+17.66 pp), 19.72% in FY2023 (-18.76 pp) and 38.48% in FY2022.
- The Q2 2026 figure marks the lowest quarterly Gross Margin in data going back to Q1 2022.
- Compared with a year earlier, Gross Margin was higher in two of the last eight quarters, with an average year-over-year change of -6.59 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q1 2026 (a gain of 79.83 percentage points); the worst was Q2 2026 (a drop of 89.25 percentage points).
- Per Business Quant data, HCWB's Gross Margin in the three quarters before Q2 2026 was 99.83% (Q1 2026), 20.00% (Q4 2025) and 20.00% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 75.71% |
| 10 | HCW Biologics | 1.02 Mn | -4.00 Mn | -93,887.00 | -69.25% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.25% |
| Mar 31, 2026 | 99.83% |
| Dec 31, 2025 | 20.00% |
| Sep 30, 2025 | 20.00% |
| Jun 30, 2025 | 20.00% |
| Mar 31, 2025 | 20.00% |
| Dec 31, 2024 | 20.00% |
| Sep 30, 2024 | 20.00% |
| Jun 30, 2024 | 29.15% |
| Mar 31, 2024 | 54.56% |
| Dec 31, 2023 | 19.08% |
| Sep 30, 2023 | 20.49% |
| Jun 30, 2023 | 19.33% |
| Mar 31, 2023 | 29.92% |
| Dec 31, 2022 | 20.00% |
| Sep 30, 2022 | 20.00% |
| Jun 30, 2022 | 36.74% |
| Mar 31, 2022 | 57.40% |
HCW Biologics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=HCWB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "HCWB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=HCWB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();